tiprankstipranks
Trending News
More News >
Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
US Market

Bicycle Therapeutics (BCYC) Financial Statements

Compare
370 Followers

Bicycle Therapeutics Financial Overview

Bicycle Therapeutics's market cap is currently $475.83M. The company's EPS TTM is $-2.878; its P/E ratio is ―; Bicycle Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.85. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 35.27M$ 26.98M$ 14.46M$ 11.70M$ 10.39M
Gross Profit$ 35.27M$ 20.51M$ 10.78M$ -33.18M$ -22.76M
Operating Income$ -209.87M$ -189.95M$ -116.65M$ -65.62M$ -51.96M
EBITDA$ -164.89M$ -183.40M$ -112.96M$ -64.08M$ -50.39M
Net Income$ -169.03M$ -180.66M$ -112.72M$ -66.82M$ -51.01M
Balance Sheet
Cash & Short-Term Investments$ 879.52M$ 526.42M$ 339.15M$ 438.68M$ 135.99M
Total Assets$ 956.87M$ 595.34M$ 410.61M$ 479.79M$ 161.15M
Total Debt$ 3.99M$ 44.96M$ 44.33M$ 44.34M$ 15.78M
Net Debt$ -875.53M$ -481.47M$ -294.83M$ -394.34M$ -120.22M
Total Liabilities$ 163.81M$ 224.41M$ 139.83M$ 133.54M$ 65.69M
Stockholders' Equity$ 793.06M$ 370.93M$ 270.78M$ 346.25M$ 95.46M
Cash Flow
Free Cash Flow$ -165.96M$ -63.56M$ -105.10M$ -16.82M$ -18.99M
Operating Cash Flow$ -164.72M$ -60.63M$ -86.11M$ -14.79M$ -17.79M
Investing Cash Flow$ -1.24M$ -2.93M$ -18.99M$ -2.03M$ -1.20M
Financing Cash Flow$ 519.75M$ 250.03M$ 6.69M$ 320.73M$ 62.84M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History

Bicycle Therapeutics Debt to Assets

Bicycle Therapeutics Cash Flow

Bicycle Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis